1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET OVERVIEW
3.1. OBESITY
3.2. BMI RANGES
3.3. MORBID OBESITY
3.4. LOSING WEIGHT
3.5. HISTORY OF INTRAGASTRIC BALLOON
3.6. RE-ENTRY OF INTRAGASTRIC BALLOON
3.7. ADVANTAGES OF INTRAGASTRIC BALLOON
3.8. COMPLICATIONS ASSOCIATED WITH INTRAGASTRIC BALLOON
3.9. WHO IS NOT SUITABLE FOR PLACEMENT OF INTRAGASTRIC BALLOON?

4. MARKET DYNAMICS
4.1. MARKET DEFINITION
4.2. KEY DRIVERS
4.2.1. HUGE OBESE POPULATION
4.2.2. RISE IN GOVERNMENT INITIATIVES
4.2.3. UNHEALTHY LIFESTYLE
4.2.4. SHORT HOSPITAL STAY AND SHORT RECOVERY TIME POST-INTRAGASTRIC BALLOONING
4.3. KEY RESTRAINTS
4.3.1. STRINGENT PRODUCT APPROVAL
4.3.2. SHORT-TERM EFFECTS OF INTRAGASTRIC BALLOONING FOR WEIGHT LOSS
4.3.3. ADVERSE EVENTS OF INTRAGASTRIC BALLOON
4.3.4. LACK OF REIMBURSEMENT FOR INTRAGASTRIC BALLOONING

5. KEY ANALYTICS
5.1. PORTER'S FIVE FORCE ANALYSIS
5.1.1. THREAT OF NEW ENTRY
5.1.2. THREAT OF SUBSTITUTION
5.1.3. BUYER'S POWER
5.1.4. SUPPLIER'S POWER
5.1.5. COMPETITIVE RIVALRY
5.2. IMPACT OF COVID-19 ON INTRAGASTRIC BALLOON IMPLANT
5.3. VALUE CHAIN ANALYSIS
5.4. SUPPLY CHAIN ANALYSIS
5.5. OPPORTUNITY MATRIX
5.6. VENDOR LANDSCAPE
5.7. KEY INVESTMENT INSIGHT

6. MARKET BY PRODUCT
6.1. SINGLE BALLOON
6.2. DUAL BALLOON
6.3. TRIPLE BALLOON

7. MARKET BY FILLING MATERIAL
7.1. SALINE-FILLED
7.2. GAS-FILLED

8. MARKET BY END-USE
8.1. CLINICS
8.2. HOSPITALS
8.3. AMBULATORY SURGICAL CENTERS

9. GEOGRAPHICAL ANALYSIS
9.1. ASIA PACIFIC
9.1.1. JAPAN
9.1.2. CHINA
9.1.3. INDIA
9.1.4. AUSTRALIA & NEW ZEALAND
9.1.5. SOUTH KOREA
9.1.6. THAILAND
9.1.7. INDONESIA
9.1.8. VIETNAM
9.1.9. REST OF ASIA PACIFIC

10. COMPANY PROFILE
10.1. APOLLO ENDOSURGERY INC
10.2. ASPIRE BARIATRICS INC
10.3. ALLURION TECHNOLOGIES INC
10.4. ALLERGAN INC
10.5. BARONOVA INC
10.6. DISTRICLASS MEDICAL
10.7. ENDALIS
10.8. HELIOSCOPIE SA
10.9. MEDSIL
10.10. OBALON THERAPEUTICS INC
10.11. RESHAPE LIFESCIENCES
10.12. SILIMED INC
10.13. SPATZ FGIA